Cargando…

Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study

Background: Lingering symptoms are frequently reported after acute SARS-CoV-2 infection, a condition known as post-COVID-19 condition (PCC). The duration and severity of PCC in immunologically naïve persons remain unclear. Furthermore, the long-term consequences of these chronic symptoms on work and...

Descripción completa

Detalles Bibliográficos
Autores principales: Benoit-Piau, Justine, Tremblay, Karine, Piché, Alain, Dallaire, Frédéric, Bélanger, Mathieu, d’Entremont, Marc-André, Pasquier, Jean-Charles, Fortin, Martin, Bourque, Catherine, Lapointe, Fanny, Betala-Belinga, Jean-François, Petit, Geneviève, Jourdan, Guillaume, Bahous, Renata, Maya, Camilo, Benzina, Amira, Faiyaz Hossain, Muhammad, Peel, Marie-Audrey, Houle, Olivier, Auger, Marie-Sandrine, Rioux, Antoine, Farand, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532279/
https://www.ncbi.nlm.nih.gov/pubmed/37762880
http://dx.doi.org/10.3390/jcm12185939
_version_ 1785111918565916672
author Benoit-Piau, Justine
Tremblay, Karine
Piché, Alain
Dallaire, Frédéric
Bélanger, Mathieu
d’Entremont, Marc-André
Pasquier, Jean-Charles
Fortin, Martin
Bourque, Catherine
Lapointe, Fanny
Betala-Belinga, Jean-François
Petit, Geneviève
Jourdan, Guillaume
Bahous, Renata
Maya, Camilo
Benzina, Amira
Faiyaz Hossain, Muhammad
Peel, Marie-Audrey
Houle, Olivier
Auger, Marie-Sandrine
Rioux, Antoine
Farand, Paul
author_facet Benoit-Piau, Justine
Tremblay, Karine
Piché, Alain
Dallaire, Frédéric
Bélanger, Mathieu
d’Entremont, Marc-André
Pasquier, Jean-Charles
Fortin, Martin
Bourque, Catherine
Lapointe, Fanny
Betala-Belinga, Jean-François
Petit, Geneviève
Jourdan, Guillaume
Bahous, Renata
Maya, Camilo
Benzina, Amira
Faiyaz Hossain, Muhammad
Peel, Marie-Audrey
Houle, Olivier
Auger, Marie-Sandrine
Rioux, Antoine
Farand, Paul
author_sort Benoit-Piau, Justine
collection PubMed
description Background: Lingering symptoms are frequently reported after acute SARS-CoV-2 infection, a condition known as post-COVID-19 condition (PCC). The duration and severity of PCC in immunologically naïve persons remain unclear. Furthermore, the long-term consequences of these chronic symptoms on work and mental health are poorly documented. Objective: To determine the outcome, the risk factors, and the impact on work and mental health associated with post-COVID-19 symptoms. Methods: This prospective population-based study assessed acute COVID-19 symptoms and their evolution for up to nine months following infection. Individuals aged 18 years and older with COVID-19 in three Canadian regions between 1 November 2020 and 31 May 2021 were recruited. Participants completed a questionnaire that was either administered by trained student investigators over the phone or self-administered online. Results: A total of 1349 participants with a mean age of 46.6 ± 16.0 years completed the questionnaire. Participants were mostly unvaccinated at the time of their COVID-19 episode (86.9%). Six hundred and twenty-two participants (48.0%) exhibited one symptom or more, at least three months post-COVID-19. Among participants with PCC, 23.0% to 37.8% experienced fatigue at the time of survey. Moreover, 6.1% expressed psychological distress. Risk factors for PCC and fatigue included female sex (OR = 1.996), higher number of symptoms (OR = 1.292), higher severity of episode (OR = 3.831), and having a mental health condition prior to the COVID-19 episode (OR = 5.155). Conclusions: In this multicenter cohort study, almost half (47%) of the participants reported persistent symptoms >3 months after acute infection. Baseline risk factors for PCC include female sex, number and severity of symptoms during acute infection, and a previous diagnosis of mental health disorder. Having PCC negatively impacted health-related quality of life and these patients were more likely to exhibit psychological distress, as well as fatigue.
format Online
Article
Text
id pubmed-10532279
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105322792023-09-28 Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study Benoit-Piau, Justine Tremblay, Karine Piché, Alain Dallaire, Frédéric Bélanger, Mathieu d’Entremont, Marc-André Pasquier, Jean-Charles Fortin, Martin Bourque, Catherine Lapointe, Fanny Betala-Belinga, Jean-François Petit, Geneviève Jourdan, Guillaume Bahous, Renata Maya, Camilo Benzina, Amira Faiyaz Hossain, Muhammad Peel, Marie-Audrey Houle, Olivier Auger, Marie-Sandrine Rioux, Antoine Farand, Paul J Clin Med Article Background: Lingering symptoms are frequently reported after acute SARS-CoV-2 infection, a condition known as post-COVID-19 condition (PCC). The duration and severity of PCC in immunologically naïve persons remain unclear. Furthermore, the long-term consequences of these chronic symptoms on work and mental health are poorly documented. Objective: To determine the outcome, the risk factors, and the impact on work and mental health associated with post-COVID-19 symptoms. Methods: This prospective population-based study assessed acute COVID-19 symptoms and their evolution for up to nine months following infection. Individuals aged 18 years and older with COVID-19 in three Canadian regions between 1 November 2020 and 31 May 2021 were recruited. Participants completed a questionnaire that was either administered by trained student investigators over the phone or self-administered online. Results: A total of 1349 participants with a mean age of 46.6 ± 16.0 years completed the questionnaire. Participants were mostly unvaccinated at the time of their COVID-19 episode (86.9%). Six hundred and twenty-two participants (48.0%) exhibited one symptom or more, at least three months post-COVID-19. Among participants with PCC, 23.0% to 37.8% experienced fatigue at the time of survey. Moreover, 6.1% expressed psychological distress. Risk factors for PCC and fatigue included female sex (OR = 1.996), higher number of symptoms (OR = 1.292), higher severity of episode (OR = 3.831), and having a mental health condition prior to the COVID-19 episode (OR = 5.155). Conclusions: In this multicenter cohort study, almost half (47%) of the participants reported persistent symptoms >3 months after acute infection. Baseline risk factors for PCC include female sex, number and severity of symptoms during acute infection, and a previous diagnosis of mental health disorder. Having PCC negatively impacted health-related quality of life and these patients were more likely to exhibit psychological distress, as well as fatigue. MDPI 2023-09-13 /pmc/articles/PMC10532279/ /pubmed/37762880 http://dx.doi.org/10.3390/jcm12185939 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Benoit-Piau, Justine
Tremblay, Karine
Piché, Alain
Dallaire, Frédéric
Bélanger, Mathieu
d’Entremont, Marc-André
Pasquier, Jean-Charles
Fortin, Martin
Bourque, Catherine
Lapointe, Fanny
Betala-Belinga, Jean-François
Petit, Geneviève
Jourdan, Guillaume
Bahous, Renata
Maya, Camilo
Benzina, Amira
Faiyaz Hossain, Muhammad
Peel, Marie-Audrey
Houle, Olivier
Auger, Marie-Sandrine
Rioux, Antoine
Farand, Paul
Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study
title Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study
title_full Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study
title_fullStr Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study
title_full_unstemmed Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study
title_short Long-Term Consequences of COVID-19 in Predominantly Immunonaive Patients: A Canadian Prospective Population-Based Study
title_sort long-term consequences of covid-19 in predominantly immunonaive patients: a canadian prospective population-based study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532279/
https://www.ncbi.nlm.nih.gov/pubmed/37762880
http://dx.doi.org/10.3390/jcm12185939
work_keys_str_mv AT benoitpiaujustine longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT tremblaykarine longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT pichealain longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT dallairefrederic longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT belangermathieu longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT dentremontmarcandre longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT pasquierjeancharles longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT fortinmartin longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT bourquecatherine longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT lapointefanny longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT betalabelingajeanfrancois longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT petitgenevieve longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT jourdanguillaume longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT bahousrenata longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT mayacamilo longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT benzinaamira longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT faiyazhossainmuhammad longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT peelmarieaudrey longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT houleolivier longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT augermariesandrine longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT riouxantoine longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy
AT farandpaul longtermconsequencesofcovid19inpredominantlyimmunonaivepatientsacanadianprospectivepopulationbasedstudy